Braun, D. A., Vemula, S. V., Cook, D., Verma, A., Carrigan, P. E., Kelly, K. A., Choueiri, T. K., Gupta, S. (2025). An integrative analysis of circulating and tumor microenvironment (TME) determinants of patient response in the Checkmate 9ER (CM 9ER) trial of nivolumab and cabozantinib (NIVO+CABO) in advanced renal cell carcinoma (aRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4511